Bibliographic Details
| Title: |
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours |
| Authors: |
Infante, Jeffrey R., Papadopoulos, Kyriakos P., Bendell, Johanna C., Patnaik, Amita, Burris, Howard A., III, Rasco, Drew, Jones, Suzanne F., Smith, Lon, Cox, Donna S., Durante, Michael, Bellew, Kevin M., Park, Joohyun (Jennifer), Le, Ngocdiep T., Tolcher, Anthony W. |
| Source: |
In European Journal of Cancer June 2013 49(9):2077-2085 |
| Database: |
ScienceDirect |
